Early and Chronic Dipeptidyl‐Peptidase‐IV Inhibition and Cardiovascular Events in Patients With Type 2 Diabetes Mellitus After an Acute Coronary Syndrome: A Landmark Analysis of the EXAMINE Trial

BACKGROUND: Antihyperglycemic therapies may increase the risk of cardiovascular events including hospitalization for heart failure. There is a paucity of data evaluating the cardiovascular safety of antihyperglycemic therapies in the high‐risk period following an acute coronary syndrome (ACS). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Abhinav, Cannon, Christopher P., White, William B., Liu, Yuyin, Bakris, George L., Cushman, William C., Zannad, Faiez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015373/
https://www.ncbi.nlm.nih.gov/pubmed/29769203
http://dx.doi.org/10.1161/JAHA.117.007649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015373/
https://www.ncbi.nlm.nih.gov/pubmed/29769203
http://dx.doi.org/10.1161/JAHA.117.007649

Ejemplares similares